Home NDC 65862-573 Valsartan
Product NDC 65862-573
11-digit product format 658620573
Labeler code 65862
Product ID 65862-573_7b329c09-5c17-4117-9cef-a383ecec90d9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Valsartan
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA202223
Marketing category ANDA
Marketing start 2015-01-05
Substance VALSARTAN
Active strength 320 mg/1
Pharmacologic classes Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes NDC auxiliary status# These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
Current NDC status page 1 of 1 · 2 matching rows.
Dataset, Scope, Product NDC table Dataset Scope Product NDC Package NDC Code Status Reporting period Source date unfinished product product 65862-573 UNFINISHED Active or certified unfinished drug listing 2026-10-05 unfinished package package 65862-573 65862-573-12 UNFINISHED Active or certified unfinished drug listing 2026-10-05
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 42 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 unfinished product product a6255e0c9aa5…a0211a219f2e…2025-12-14 21:27 UTC · source 2025-12-05 unfinished package package 65862-573-12 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 unfinished product product 1d862106b807…00c93037cd84…2025-08-26 23:59 UTC · source 2025-08-26 unfinished package package 65862-573-12 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 unfinished product product 390b4c401c3f…2c692c2daee3…2025-05-15 14:59 UTC · source 2025-05-14 unfinished package package 65862-573-12 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 unfinished product product e30019b0c005…a3f0b14938b7…2025-04-01 07:37 UTC · source 2025-03-31 unfinished package package 65862-573-12 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 unfinished product product bbbc9f937eca…946b9c97cf81…2025-03-01 13:19 UTC · source 2025-02-28 unfinished package package 65862-573-12 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 unfinished product product f268b84574a6…26285f5ac5df…2025-02-27 05:24 UTC · source 2025-02-26 unfinished package package 65862-573-12 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 unfinished product product f764e8902f78…92046438deef…2025-02-01 13:13 UTC · source 2025-01-31 unfinished package package 65862-573-12 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 unfinished product product 68b1e3bced9e…98a755eb8bc6…2025-01-20 13:05 UTC · source 2025-01-17 unfinished package package 65862-573-12 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 unfinished product product 05c55d027831…ca05dca9dc4c…2024-11-29 20:42 UTC · source 2024-11-29 unfinished package package 65862-573-12 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 unfinished product product 48b4f40e6753…c7c7a00d2afa…2024-11-09 02:36 UTC · source 2024-11-08 unfinished package package 65862-573-12 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 unfinished product product 27f29a85d7e4…1372111e901f…2024-10-09 02:27 UTC · source 2024-10-08 unfinished package package 65862-573-12 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 unfinished product product 8d62ce987f31…9fe9ef23e30d…2024-07-10 04:00 UTC · source 2024-07-09 unfinished package package 65862-573-12 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished product product d1e113ab4d42…063ee3eb0a1d…2024-05-28 21:11 UTC · source 2024-05-28 unfinished package package 65862-573-12 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 unfinished product product 50b4072663b7…eae3003ed65e…2024-05-15 03:51 UTC · source 2024-05-14 unfinished package package 65862-573-12 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 unfinished product product 906f6e251498…bf70b80e44f0…2022-04-09 23:13 UTC · source 2022-04-08 unfinished package package 65862-573-12 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 unfinished product product 6db9cb8d1e19…3449e1ec5b70…2021-12-27 23:28 UTC · source 2021-12-27 unfinished package package 65862-573-12 6db9cb8d1e19…3449e1ec5b70…2021-02-18 23:40 UTC · source 2021-02-18 unfinished product product 8fc7167e32ce…e96bbc724034…2021-02-18 23:40 UTC · source 2021-02-18 unfinished package package 65862-573-12 8fc7167e32ce…e96bbc724034…2020-12-18 03:04 UTC · source 2020-12-17 unfinished product product 4184dd79f89f…545327b3e20f…2020-12-18 03:04 UTC · source 2020-12-17 unfinished package package 65862-573-12 4184dd79f89f…545327b3e20f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished product product 4bd3596a7b87…5c64c6f6865f…2020-06-10 20:45 UTC · source 2020-06-10 unfinished package package 65862-573-12 4bd3596a7b87…5c64c6f6865f…2019-12-08 06:16 UTC · source 2019-12-05 unfinished product product 263afe128892…91768de4ddbe…2019-12-08 06:16 UTC · source 2019-12-05 unfinished package package 65862-573-12 263afe128892…91768de4ddbe…2019-06-01 22:24 UTC · source 2019-05-30 unfinished product product 5b2001dcd8f5…54b53d4dc9e4…2019-06-01 22:24 UTC · source 2019-05-30 unfinished package package 65862-573-12 5b2001dcd8f5…54b53d4dc9e4…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202223-001 VALSARTAN VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 A202223-002 VALSARTAN VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 A202223-003 VALSARTAN VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 A202223-004 VALSARTAN VALSARTAN 320MG TABLET / ORAL AB 2015-01-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202223-001 VALSARTAN 40MG TABLET / ORAL AB 2015-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202223-002 VALSARTAN 80MG TABLET / ORAL AB 2015-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202223-003 VALSARTAN 160MG TABLET / ORAL AB 2015-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202223-004 VALSARTAN 320MG TABLET / ORAL AB 2015-01-05 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Valsartan
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VALSARTAN 320 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 80M03YXJ7I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 349199 Internal RxNorm lookup 349200 Internal RxNorm lookup 349201 Internal RxNorm lookup 349483 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65862-573-05 Valsartan 500 in 1 BOTTLE TABLET, FILM COATED 500 17 65862-573-90 Valsartan 90 in 1 BOTTLE TABLET, FILM COATED 90 17
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded VALSARTAN ACTIVE INGREDIENT 80M03YXJ7I VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 VALSARTAN ACTIVE MOIETY 80M03YXJ7I VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 HYPROMELLOSE 2910 (5 MPA.S) INACTIVE INGREDIENT R75537T0T4 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 POLYETHYLENE GLYCOL 8000 INACTIVE INGREDIENT Q662QK8M3B VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65862-573 VALSARTAN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] 17 Current NDC, Legacy NDC, 2 package rows 20240521_a81a72dd-e828-4208-af9b-bb9ac4938537.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 65862-573-05 65862057305 500 TABLET, FILM COATED in 1 BOTTLE (65862-573-05) 2015-01-05 0000-00-00 No No Current 65862-573-12 65862057312 1200 TABLET, FILM COATED in 1 BAG (65862-573-12) 05-JAN-15 Current 65862-573-90 65862057390 90 TABLET, FILM COATED in 1 BOTTLE (65862-573-90) 2015-01-05 0000-00-00 No No Current